-
公开(公告)号：US20230390249A1
公开(公告)日：2023-12-07
申请号：US18453431
申请日：2023-08-22
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor： Peter Tai Wah Cheng , Robert F. Kaltenbach, III , Jun Li , Jun Shi , Yan Shi , Shiwei Tao , Hao Zhang , Suresh Dhanusu , Kumaravel Selvakumar , Ramesh Babu Reddigunta , Steven J. Walker , Lawrence J. Kennedy , James R. Corte , Tianan Fang , Sutjano Jusuf
IPC: A61K31/4192 , C07D401/14 , C07D249/06 , A61K31/27 , A61K31/454 , C07D401/04
CPC classification number: A61K31/4192 , C07D401/14 , C07D249/06 , A61K31/27 , A61K31/454 , C07D401/04 , A61K31/41
Abstract: The present invention provides compounds of Formula (I):
or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein all the variables are as defined herein. These compounds are selective LPA receptor inhibitors.-
公开(公告)号：US20170360759A1
公开(公告)日：2017-12-21
申请号：US15628104
申请日：2017-06-20
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor： Peter Tai Wah Cheng , Robert F. Kaltenbach, III , Jun LI , Jun Shi , Yan Shi , Shiwei Tao , Hao Zhang , Suresh Dhanusu , Kumaravel Selvakumar , Ramesh Babu Reddigunta , Steven J. Walker , Lawrence J. Kennedy , James R. Corte , Tianan Fang , Sutjano Jusuf
IPC: A61K31/4192 , A61K31/27 , C07D401/04 , A61K31/454 , C07C62/10 , A61K31/41
CPC classification number: A61K31/4192 , A61K31/27 , A61K31/41 , A61K31/454 , C07C62/10 , C07D249/06 , C07D401/04 , C07D401/14
Abstract: The present invention provides compounds of Formula (I): or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein all the variables are as defined herein. These compounds are selective LPA receptor inhibitors.
-
公开(公告)号：US11007180B2
公开(公告)日：2021-05-18
申请号：US16732387
申请日：2020-01-02
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor： Peter Tai Wah Cheng , Robert F. Kaltenbach, III , Jun Li , Jun Shi , Yan Shi , Shiwei Tao , Hao Zhang , Suresh Dhanusu , Kumaravel Selvakumar , Ramesh Babu Reddigunta , Steven J. Walker , Lawrence J. Kennedy , James R. Corte , Tianan Fang , Sutjano Jusuf
IPC: C07D401/04 , A61K31/4192 , C07D401/14 , C07D249/06 , A61K31/27 , A61K31/454 , A61K31/41 , C07C62/10
Abstract: The present invention provides compounds of Formula (I): or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein all the variables are as defined herein. These compounds are selective LPA receptor inhibitors.
-
公开(公告)号：US10071078B2
公开(公告)日：2018-09-11
申请号：US15628104
申请日：2017-06-20
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor： Peter Tai Wah Cheng , Robert F. Kaltenbach, III , Jun Li , Jun Shi , Yan Shi , Shiwei Tao , Hao Zhang , Suresh Dhanusu , Kumaravel Selvakumar , Ramesh Babu Reddigunta , Steven J. Walker , Lawrence J. Kennedy , James R. Corte , Tianan Fang , Sutjano Jusuf
IPC: C07D401/04 , A61K31/4192 , A61K31/27 , A61K31/454 , C07D401/14 , C07D249/06 , A61K31/41 , C07C62/10
CPC classification number: A61K31/4192 , A61K31/27 , A61K31/41 , A61K31/454 , C07C62/10 , C07D249/06 , C07D401/04 , C07D401/14
Abstract: The present invention provides compounds of Formula (I): or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein all the variables are as defined herein. These compounds are selective LPA receptor inhibitors.
-
公开(公告)号：US20250057815A1
公开(公告)日：2025-02-20
申请号：US18822597
申请日：2024-09-03
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor： Peter Tai Wah Cheng , Robert F. Kaltenbach, III , Jun Li , Jun Shi , Yan Shi , Shiwei Tao , Hao Zhang , Suresh Dhanusu , Kumaravel Selvakumar , Ramesh Babu Reddigunta , Steven J. Walker , Lawrence J. Kennedy , James R. Corte , Tianan Fang , Sutjano Jusuf
IPC: A61K31/4192 , A61K31/27 , A61K31/41 , A61K31/454 , C07C62/10 , C07D249/06 , C07D401/04 , C07D401/14
Abstract: The present invention provides compounds of Formula (I): or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein all the variables are as defined herein. These compounds are selective LPA receptor inhibitors.
-
Patent Agency Ranking
公开(公告)号：US11261174B2
公开(公告)日：2022-03-01
申请号：US16954221
申请日：2018-12-18
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor： Peter Tai Wah Cheng , Jun Li , Yan Shi , Ying Wang , Hao Zhang , Lawrence J. Kennedy , Steven J. Walker , Ramesh Babu Reddigunta
IPC: C07D231/12 , C07D401/04 , C07D403/04 , A61K31/415 , A61K31/4427 , A61K31/496 , A61P43/00 , A61P17/02 , A61P35/00
Abstract: The present invention provides compounds of Formula (I) or a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein all the variables are as defined herein. These compounds are selective LPA receptor inhibitors.
-
公开(公告)号：US20210244711A1
公开(公告)日：2021-08-12
申请号：US17221859
申请日：2021-04-05
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor： PETER TAI WAH CHENG , Robert F. Kaltenbach, III , Jun Li , Jun Shi , Yan Shi , Shiwei Tao , Hao Zhang , Suresh Dhanusu , Kumaravel Selvakumar , Ramesh Babu Reddigunta , Steven J. Walker , Lawrence J. Kennedy , James R. Corte , Tianan Fang , Sutjano Jusuf
IPC: A61K31/4192 , C07D401/14 , C07D249/06 , A61K31/27 , A61K31/454 , C07D401/04
Abstract: The present invention provides compounds of Formula (I): or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein all the variables are as defined herein. These compounds are selective LPA receptor inhibitors.
-
公开(公告)号：US20220249443A1
公开(公告)日：2022-08-11
申请号：US17718760
申请日：2022-04-12
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor： Peter Tai Wah Cheng , Robert F. Kaltenbach, III , Jun Li , Jun Shi , Yan Shi , Shiwei Tao , Hao Zhang , Suresh Dhanusu , Kumaravel Selvakumar , Ramesh Babu Reddigunta , Steven J. Walker , Lawrence J. Kennedy , James R. Corte , Tianan Fang , Sutjano Jusuf
IPC: A61K31/4192 , C07D401/14 , C07D249/06 , A61K31/27 , A61K31/454 , C07D401/04
Abstract: The present invention provides compounds of Formula (I): or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein all the variables are as defined herein. These compounds are selective LPA receptor inhibitors.
-
公开(公告)号：US20200308148A1
公开(公告)日：2020-10-01
申请号：US16954221
申请日：2018-12-18
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor： Peter Tai Wah Cheng , Jun Li , Yan Shi , Ying Wang , Hao Zhang , Lawrence J. Kennedy , Steven J. Walker , Ramesh Babu Reddigunta
IPC: C07D403/04 , C07D401/04 , C07D231/12 , A61P35/00 , A61P17/02
Abstract: The present invention provides compounds of Formula (I) or a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein all the variables are as defined herein. These compounds are selective LPA receptor inhibitors.
-
公开(公告)号：US10576062B2
公开(公告)日：2020-03-03
申请号：US16038739
申请日：2018-07-18
Applicant: Bristol-Myers Squibb Company
Inventor： Peter Tai Wah Cheng , Robert F. Kaltenbach, III , Jun Li , Jun Shi , Yan Shi , Shiwei Tao , Hao Zhang , Suresh Dhanusu , Kumaravel Selvakumar , Ramesh Babu Reddigunta , Steven J. Walker , Lawrence J. Kennedy , James R. Corte , Tianan Fang , Sutjano Jusuf
IPC: C07D401/14 , C07D249/06 , A61K31/27 , A61K31/4192 , A61K31/454 , C07D401/04 , A61K31/41 , C07C62/10
Abstract: The present invention provides compounds of Formula (I): or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein all the variables are as defined herein. These compounds are selective LPA receptor inhibitors.
-
-
-
-
-
-
-
-
-
Search Results
10
records
(took 0.02 seconds)
